AstraZeneca Seeks Full Rehearing Of Generic Drugmaker Win

AstraZeneca AB on Tuesday asked for a full rehearing before the Federal Circuit in its ongoing efforts to block Hanmi USA Inc.'s generic version of acid reflux drug Nexium, arguing that...

Already a subscriber? Click here to view full article